questionText: To ask the Secretary of State for Health and Social Care what discussions he has had with NICE on the potential impact of its approval of medicines for use in the NHS on (a) economic productivity, (b) health outcomes and (c) reducing the burden of disease on (i) patients and (ii) caregivers.
answerText: Departmental officials regularly discuss a range of issues with colleagues in the National Institute for Health and Care Excellence (NICE), including the impact of its recommendations.NICE develops its guidance independently and based on an assessment of ...
heading: Prescription Drugs